Nifedipine description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Nifedipine

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

NIFEDIPINE DESCRIPTION


Nifedipine




System Components and Performance





CLINICAL PHARMACOLOGY



Mechanism of Action

A) Angina


1) Relaxation and Prevention of Coronary Artery Spasm


2) Reduction of Oxygen Utilization


B) Hypertension



PHARMACOKINETICS AND METABOLISM




Hemodynamics


Electrophysiologic Effects


INDICATIONS & USAGE

I. Vasospastic Angina


II. Chronic Stable Angina (Classical Effort-Associated Angina)


WARNINGS

III. Hypertension


NIFEDIPINE CONTRAINDICATIONS



WARNINGS

Excessive Hypotension




Increased Angina and/or Myocardial Infarction


Beta Blocker Withdrawal


Congestive Heart Failure


Gastrointestinal Obstruction Requiring Surgery




PRECAUTIONS

General

Hypotension
WARNINGS

Peripheral Edema


INFORMATION FOR PATIENTS



LABORATORY TESTS






DRUG INTERACTIONS

Beta-adrenergic Blocking Agents
INDICATIONS AND USAGEWARNINGS

Long-acting Nitrates


Digitalis


Coumarin Anticoagulants


Cimetidine


CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY



PREGNANCY

Pregnancy Category C



PEDIATRIC USE



NIFEDIPINE ADVERSE REACTIONS





























PRECAUTIONS



OVERDOSAGE






DOSAGE & ADMINISTRATION






Co-Administration with Other Antianginal Drugs
PRECAUTIONS: Drug Interactions

HOW SUPPLIED
















STORAGE AND HANDLING





PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Nifedipine

Nifedipine

Nifedipine TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-588(NDC:62175-260)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
nifedipine NIFEDIPINE 30 mg

Inactive Ingredients

Ingredient Name Strength
FERROSOFERRIC OXIDE
CELLULOSE ACETATE
SILICON DIOXIDE
HYPROMELLOSES
lactose monohydrate
cellulose, microcrystalline
MAGNESIUM STEARATE
polyethylene glycol
POLYSORBATE 20
povidone
propylene glycol
ferric oxide red
SODIUM CHLORIDE
titanium dioxide
triacetin

Product Characteristics

Color Size Imprint Code Shape
pink 9 mm KU;260 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-588-20 100 in 1 CANISTER

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077127 2011-10-17


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.